146 related articles for article (PubMed ID: 11104865)
1. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system.
Filippatos GS; Tsilias K; Venetsanou K; Karambinos E; Manolatos D; Kranidis A; Antonellis J; Kardaras F; Anthopoulos L; Baltopoulos G
Int J Cardiol; 2000; 76(2-3):117-22. PubMed ID: 11104865
[TBL] [Abstract][Full Text] [Related]
2. The significance of leptin in human--do we know it yet?
Doehner W; Anker SD
Int J Cardiol; 2000; 76(2-3):122-4. PubMed ID: 11104866
[No Abstract] [Full Text] [Related]
3. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.
Murdoch DR; Rooney E; Dargie HJ; Shapiro D; Morton JJ; McMurray JJ
Heart; 1999 Sep; 82(3):352-6. PubMed ID: 10455089
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia.
Zhao SP; Zeng LH
Int J Cardiol; 1997 Feb; 58(3):257-61. PubMed ID: 9076551
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.
Takahashi M; Terashima M; Takagane A; Oyama K; Fujiwara H; Wakabayashi G
Int J Clin Oncol; 2009 Aug; 14(4):315-20. PubMed ID: 19705241
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer.
Dülger H; Alici S; Sekeroğlu MR; Erkog R; Ozbek H; Noyan T; Yavuz M
Int J Clin Pract; 2004 Jun; 58(6):545-9. PubMed ID: 15311551
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
Nozaki N; Yamaguchi S; Shirakabe M; Nakamura H; Tomoike H
Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin concentration in heart failure patients: does the literature reflect reality?
Filippatos G; Tsilias K; Baltopoulos G; Anthopoulos L
Eur Heart J; 2000 Feb; 21(4):334-5. PubMed ID: 10653682
[No Abstract] [Full Text] [Related]
10. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure.
Schulze PC; Kratzsch J; Linke A; Schoene N; Adams V; Gielen S; Erbs S; Moebius-Winkler S; Schuler G
Eur J Heart Fail; 2003 Jan; 5(1):33-40. PubMed ID: 12559213
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble form of Fas molecule in patients with congestive heart failure.
Okuyama M; Yamaguchi S; Nozaki N; Yamaoka M; Shirakabe M; Tomoike H
Am J Cardiol; 1997 Jun; 79(12):1698-701. PubMed ID: 9202370
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.
Genth-Zotz S; von Haehling S; Bolger AP; Kalra PR; Wensel R; Coats AJ; Anker SD
Am J Cardiol; 2002 Dec; 90(11):1226-30. PubMed ID: 12450603
[TBL] [Abstract][Full Text] [Related]
13. [Leptin serum levels in cachectic and non-cachectic lung cancer patients].
Weryńska B; Kosacka M; Gołecki M; Jankowska R
Pneumonol Alergol Pol; 2009; 77(6):500-6. PubMed ID: 20013699
[TBL] [Abstract][Full Text] [Related]
14. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
[TBL] [Abstract][Full Text] [Related]
15. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
McMurray J; Abdullah I; Dargie HJ; Shapiro D
Br Heart J; 1991 Nov; 66(5):356-8. PubMed ID: 1747295
[TBL] [Abstract][Full Text] [Related]
16. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
18. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
[TBL] [Abstract][Full Text] [Related]
19. Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract.
Diakowska D; Krzystek-Korpacka M; Markocka-Maczka K; Diakowski W; Matusiewicz M; Grabowski K
Cytokine; 2010 Aug; 51(2):132-7. PubMed ID: 20541434
[TBL] [Abstract][Full Text] [Related]
20. [Alteration and clinical significance of plasma levels of tumor necrosis factor in chronic heart failure].
Zeng L; Zhao S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):379-81. PubMed ID: 11189399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
